|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/7125 | |||
| A61P 3/06 |
| (11) | Number of the document | 3011028 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14813192.3 |
| Date of filing the European patent application | 2014-06-23 | |
| (97) | Date of publication of the European application | 2016-04-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/043731 |
| Date | 2014-06-23 |
| (87) | Number | WO 2014/205451 |
| Date | 2014-12-24 |
| (30) | Number | Date | Country code |
| 201361838190 P | 2013-06-21 | US | |
| 201361871683 P | 2013-08-29 | US |
| (72) |
PRAKASH, Thazha, P., US
LIMA, Walter, F., US
KINBERGER, Garth, A., US
MURRAY, Heather, US
SWAYZE, Eric, E., US
CROOKE, Stanley, T., US
|
| (73) |
Ionis Pharmaceuticals, Inc.,
2855 Gazelle Court, Carlsbad, CA 92010,
US
|
| (54) | COMPOSITIONS AND METHODS FOR MODULATION OF TARGET NUCLEIC ACIDS |
| COMPOSITIONS AND METHODS FOR MODULATION OF TARGET NUCLEIC ACIDS |